Concurrent Weekly Cisplatin Versus Triweekly Cisplatin with Radiotherapy in the Treatment of Cervical Cancer: A Metaanalysis Result

被引：14
作者：
Hu, Yan [1 ]
Cai, Zhi-Qiang [1 ]
Su, Xiao-Yan [1 ]
机构：
[1] First Peoples Hosp Jingzhou, Dept Oncol, Jinzhou, Peoples R China
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2012年 / 13卷 / 09期
关键词：
Cisplatin; cervical cancer; weekly; triweekly; chemoradiation; GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; COMBINATION CHEMOTHERAPY; PELVIC IRRADIATION; RANDOMIZED-TRIAL; CARCINOMA; CHEMORADIOTHERAPY; OUTCOMES;
D O I：
10.7314/APJCP.2012.13.9.4301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aims: To evaluate the adverse effect and survival outcome of weekly and triweekly cisplatin with radiotherapy in treatment of cervical cancer. Methods: After an extensive literature search between 1995-2011, we analyzed 7 studies to compare weekly cisplatin and triweekly cisplatin combined radiotherapy. Results: Our analysis established that weekly cisplatin has a lower risk of hematologic toxicity than triweekly cisplatin with concurrent radiotherapy in the treatment of cervical cancer. However, there were no differences in progression free survival and overall survival between weekly cisplatin and triweekly cisplatin (p>0.05). Conclusions: Weekly cisplatin combined with concurrent radiation has lower risk in hematologic toxicity than triweekly cisplatin, but does not improve survival. Triweekly cisplatin treatment has longer intervals and is therefore more convenient. Clinicians and patients can choose either weekly cisplatin or triweekly cisplatin combined radiotherapy for cervical cancer.
引用
收藏
页码：4301 / 4304
页数：4
相关论文
共 18 条
[1]   Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity [J].
Barnholtz-Sloan, Jill ;
Patel, Nitin ;
Rollison, Dana ;
Kortepeter, Karl ;
MacKinnon, Jill ;
Giuliano, Anna .
CANCER CAUSES & CONTROL, 2009, 20 (07) :1129-1138
[2]   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 [J].
Eifel, PJ ;
Winter, K ;
Morris, M ;
Levenback, C ;
Grigsby, PW ;
Cooper, J ;
Rotman, M ;
Gershenson, D ;
Mutch, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :872-880
[3]   Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy? [J].
Harrison, L ;
Blackwell, K .
ONCOLOGIST, 2004, 9 :31-40
[4]   The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A gynecologic oncology group study [J].
Hernandez, E ;
Donohue, KA ;
Anderson, LL ;
Heller, PB ;
Stehman, FB .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :137-142
[5]  
Idei Tomoko, 2003, Gan To Kagaku Ryoho, V30, P505
[6]   Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients [J].
Katanyoo, Kanyarat ;
Tangjitgamol, Siriwan ;
Chongthanakorn, Marisa ;
Tantivatana, Thanatip ;
Manusirivithaya, Sumonmal ;
Rongsriyam, Kanisa ;
Cholpaisal, Atchima .
GYNECOLOGIC ONCOLOGY, 2011, 123 (03) :571-576
[7]   Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dos,e rate brachytherapy for locally advanced cervical cancer [J].
Kim, Young Seok ;
Shin, Seong Soo ;
Nam, Joo-Hyun ;
Kim, Young-Tak ;
Kim, Yong-Man ;
Kim, Jong Hoon ;
Choi, Eun Kyung .
GYNECOLOGIC ONCOLOGY, 2008, 108 (01) :195-200
[8]  
Kim Young Seok, 2005, Cancer Res Treat, V37, P37, DOI 10.4143/crt.2005.37.1.37
[9]   Chemoradiotherapy for Cervical Cancer in 2010 [J].
Klopp, Ann H. ;
Eifel, Patricia J. .
CURRENT ONCOLOGY REPORTS, 2011, 13 (01) :77-85
[10]   Weekly Cisplatin Therapy Compared With Triweekly Combination Chemotherapy as Concurrent Adjuvant Chemoradiation Therapy After Radical Hysterectomy for Cervical Cancer [J].
Lee, Hae Nam ;
Lee, Keun Ho ;
Lee, Dae Woo ;
Lee, Yong Seok ;
Park, Eun Kyung ;
Park, Jong Sup .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (01) :128-136
12